Trademark: 79384566
Word
MELBRIXYN
Status Date
Tuesday, July 23, 2024
Filing Date
Monday, October 2, 2023
Published for Opposition
Tuesday, July 23, 2024
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Dec 12, 2023
Limitation From Original Application Entered
Dec 7, 2023
Sn Assigned For Sect 66a Appl From Ib
Dec 15, 2023
New Application Office Supplied Data Entered
Dec 19, 2023
Application Filing Receipt Mailed
Jan 2, 2024
Teas Change Of Owner Address Received
Jan 2, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 2, 2024
Teas Change Of Correspondence Received
Jan 2, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 2, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 2, 2024
Teas Change Of Domestic Representatives Address
Jan 18, 2024
Assigned To Examiner
Jan 23, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Previous Allowance Count Withdrawn
Jan 24, 2024
Non-Final Action Written
Jan 25, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Feb 13, 2024
Non-Final Action (Ib Refusal) Withdrawn For Review
Apr 4, 2024
Non-Final Action Written
Apr 5, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Apr 23, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Apr 23, 2024
Refusal Processed By Mpu
May 14, 2024
Refusal Processed By Ib
Jun 7, 2024
Correspondence Received In Law Office
Jun 7, 2024
Teas/Email Correspondence Entered
Jun 7, 2024
Teas Response To Office Action Received
Jun 17, 2024
Approved For Pub - Principal Register
Jul 3, 2024
Notification Of Notice Of Publication E-Mailed
Jul 23, 2024
Published For Opposition
Jul 23, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
